Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
Heba Alshaker(University of East Anglia), Dmitri Pchejetski(University of East Anglia), Aun Muhammad(Whittington Hospital), Mathias Winkler(National Health Service), Albandri Alfraidi(Imperial College London), Keith Sacco(Phoenix Children's Hospital)
Cited by 76
Related Papers
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1
|Leukemia|2005|171
Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
|European Heart Journal|2011|163